Toyota|$17.85 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$26.14 (¥4,142)-1.64%▼ (in JPY terms)
SoftBank|$22.40 (¥3,549)-10.83%▼ (in JPY terms)
MUFG|$20.35 (¥3,224)-6.52%▼ (in JPY terms)
Keyence|$440.27 (¥69,750)-3.65%▼ (in JPY terms)
Nintendo|$51.62 (¥8,178)-7.91%▼ (in JPY terms)
NTT|$1.01 (¥160)-2.85%▼ (in JPY terms)
Takeda|$41.41 (¥6,560)-4.76%▼ (in JPY terms)
Tokyo Electron|$52.16 (¥8,263)-5.60%▼ (in JPY terms)
Recruit|$107.31 (¥17,000)-5.61%▼ (in JPY terms)
ITOCHU|$14.15 (¥2,241)-6.45%▼ (in JPY terms)
Honda|$11.56 (¥1,831)-5.69%▼ (in JPY terms)
Shin-Etsu|$33.53 (¥5,312)-6.69%▼ (in JPY terms)
Tokio Marine|$3.60 (¥570)-5.97%▼ (in JPY terms)
Fast Retailing|$492.03 (¥77,950)-3.79%▼ (in JPY terms)
Toyota|$17.85 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$26.14 (¥4,142)-1.64%▼ (in JPY terms)
SoftBank|$22.40 (¥3,549)-10.83%▼ (in JPY terms)
MUFG|$20.35 (¥3,224)-6.52%▼ (in JPY terms)
Keyence|$440.27 (¥69,750)-3.65%▼ (in JPY terms)
Nintendo|$51.62 (¥8,178)-7.91%▼ (in JPY terms)
NTT|$1.01 (¥160)-2.85%▼ (in JPY terms)
Takeda|$41.41 (¥6,560)-4.76%▼ (in JPY terms)
Tokyo Electron|$52.16 (¥8,263)-5.60%▼ (in JPY terms)
Recruit|$107.31 (¥17,000)-5.61%▼ (in JPY terms)
ITOCHU|$14.15 (¥2,241)-6.45%▼ (in JPY terms)
Honda|$11.56 (¥1,831)-5.69%▼ (in JPY terms)
Shin-Etsu|$33.53 (¥5,312)-6.69%▼ (in JPY terms)
Tokio Marine|$3.60 (¥570)-5.97%▼ (in JPY terms)
Fast Retailing|$492.03 (¥77,950)-3.79%▼ (in JPY terms)

admin

2026-10-16 Eisai Co.,Ltd. “At the European Society for Medical Oncology (ESMO) Annual Meeting 2026, we will present further evidence in the field of oncology—new insights into Lenvima® (lenvatinib)-based combination therapy from the Phase III LITESPARK-011 and LITESPARK-012 clinical trials for advanced renal cell carcinoma, new findings from translational studies of advanced or recurrent endometrial cancer obtained from exploratory biomarker analysis of the Phase III LEAP-001 trial, and new findings from "Patients Raise Their Voices."”

by

2026-10-16 Eisai Co.,Ltd. “At the European Society for Medical Oncology (ESMO) Annual Meeting 2026, we w … 続きを読む

2026-10-16 Shionogi & Co.,Ltd. “NEDO's "Prize-Based Program/Development of Social Problem Solutions Using Quantum Computing" awarded first place in the Quality of Life (QoL) category – recognized for its drug discovery research approach utilizing quantum computers and supercomputers.”

by

2026-10-16 Shionogi & Co.,Ltd. “NEDO's "Prize-Based Program/Development of Social Problem … 続きを読む

Sister site: Lagrange Financial News (Japanese-language)
Contact